6 active trials 1 recruiting 7 disease areas 7 changes in 30 days
| Phase 1 | 5 | |
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT03594981 | Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection… | Viral Infection | Active, Not Recruiting | 2026-08-14 |
| Phase 1 | ||||
| NCT02203903 | Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented… | Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS | Recruiting | 2026-08-14 |
| NCT03652545 | Multi-antigen T Cell Infusion Against Neuro-oncologic Disease | Brain Tumor | Active, Not Recruiting | 2026-08-14 |
| NCT03843294 | Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma | Hodgkin Lymphoma | Active, Not Recruiting | 2026-08-14 |
| NCT04248192 | Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD)… | HIV-Infected Individuals | Active, Not Recruiting | 2026-08-14 |
| NCT04236479 | Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP) | Congenital Heart Disease (CHD) | Active, Not Recruiting | 2026-06-02 |
Acute Myeloid Leukemia (AML) (1) · DLBCL (1) · Heart Disease (1) · Hodgkin Lymphoma (1) · Leukemia (1) · Myelodysplastic Syndromes (MDS) (1) · Non-Hodgkin Lymphoma (1)